CD274 and melanoma: In mice, IBI322 was shown to effectively accumulate in PD-L1 positive tumors and induce complete tumor regression of Raji-hPD-L1 (lymphoblast-like cells) and A375 (malignant melanoma cells), with only marginal RBC depletion [48].